Qiagen N.V. (BIT:1QGEN)
43.09
-0.19 (-0.43%)
At close: Feb 11, 2026
Qiagen Market Cap
Qiagen has a market cap or net worth of €8.87 billion as of February 11, 2026. Its market cap has decreased by -7.86% in one year.
Market Cap
8.87B
Enterprise Value
9.34B
Revenue
1.78B
Ranking
n/a
PE Ratio
24.51
Stock Price
€43.09
Market Cap Chart
Since June 28, 1996, Qiagen's market cap has increased from 154.92M to 8.87B, an increase of 5,624.49%. That is a compound annual growth rate of 14.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 8.85B | 6.50% |
| Dec 31, 2025 | 8.31B | -13.12% |
| Dec 31, 2024 | 9.56B | 6.63% |
| Dec 29, 2023 | 8.97B | -15.62% |
| Dec 30, 2022 | 10.63B | -4.23% |
| Dec 31, 2021 | 11.10B | 12.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.66B |
| DiaSorin | 3.96B |
| Amplifon | 3.05B |
| EL.En. | 1.14B |
| Safilo Group | 869.90M |
| Philogen | 853.60M |
| Pharmanutra | 597.32M |
| Garofalo Health Care | 489.36M |